Filing Details

Accession Number:
0001140361-18-043653
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-26 13:39:56
Reporting Period:
2018-11-21
Accepted Time:
2018-11-26 13:39:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1398733 Aquestive Therapeutics Inc. AQST Pharmaceutical Preparations (2834) 208623253
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1739025 T. John Maxwell C/O Aquestive Therapeutics, Inc.
30 Technology Drive
Warren NJ 07059
Svp-Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-21 10,000 $9.80 148,614 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 10,000 shares owned jointly with Mr. Maxwell's spouse.